Hookipa Pharma currently holds roughly 82.27 M in cash with (64.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.75, which can makes it an attractive takeover target, given it will continue generating positive cash flow. On a scale of 0 to 100, Hookipa Pharma holds a performance score of 3. The company retains a Market Volatility (i.e., Beta) of 1.1918, which attests to a somewhat significant risk relative to the market. Let's try to break down what Hookipa's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Hookipa Pharma will likely underperform. Although it is vital to follow Hookipa Pharma current price history, it is good to be conservative about what you can do with the information regarding equity current price movements. The philosophy towards determining future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. By evaluating Hookipa Pharma technical indicators, you can presently evaluate if the expected return of 0.44% will be sustainable into the future. Please utilizes Hookipa Pharma maximum drawdown, as well as the relationship between the expected short fall and rate of daily change to make a quick decision on whether Hookipa Pharma current trending patterns will revert.
